Creative Planning
FLNA

Creative Planning’s Filana Therapeutics FLNA Stock Holding History

Creative Planning’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-6,831
Closed -$201K – 3667
2024
Q3 		$201K Buy
+6,831
New +$157K ﹤0.01% 2834
2023
Q3 		– Sell
-12,616
Closed -$309K – 3016
2023
Q2 		$309K Buy
12,616
+1,125
+10% +$27.1K ﹤0.01% 1891
2023
Q1 		$277K Sell
11,491
-1,483
-11% -$41.1K ﹤0.01% 1878
2022
Q4 		$383K Sell
12,974
-149
-1% -$5.36K ﹤0.01% 1570
2022
Q3 		$549K Buy
13,123
+718
+6% +$19.4K ﹤0.01% 1277
2022
Q2 		$349K Sell
12,405
-2,333
-16% -$58.9K ﹤0.01% 1514
2022
Q1 		$547K Sell
14,738
-4,185
-22% -$177K ﹤0.01% 1277
2021
Q4 		$827K Buy
18,923
+750
+4% +$39.3K ﹤0.01% 1041
2021
Q3 		$1.13M Buy
+18,173
New +$1.52M ﹤0.01% 889
2021
Q2 		– Sell
-18,498
Closed -$831K – 2507
2021
Q1 		$831K Buy
18,498
+4,350
+31% +$171K ﹤0.01% 1139
2020
Q4 		$96K Sell
14,148
-28,450
-67% -$254K ﹤0.01% 2034
2020
Q3 		$490K Buy
42,598
+20,950
+97% +$94.4K ﹤0.01% 1151
2020
Q2 		$67K Buy
21,648
+8,350
+63% +$37.9K ﹤0.01% 1727
2020
Q1 		$55K Buy
+13,298
New +$88K ﹤0.01% 1620
2017
Q3 		– Sell
-48
Closed – – 3368
2017
Q2 		$0 Hold
48
– – ﹤0.01% 4800
2017
Q1 		$0 Hold
48
– – ﹤0.01% 4872
2016
Q4 		$0 Buy
+48
New +$223 ﹤0.01% 4805
2013
Q4 		– Sell
-171
Closed -$3K – 3449
2013
Q3 		$3K Buy
+171
New +$2.99K ﹤0.01% 2906

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

Creative Planning's FLNA Position: Q4 2024 in Review

Creative Planning sold out of Filana Therapeutics (FLNA) in Q4 2024, closing a stake of 6,831 shares — an estimated $201K sold.

Creative Planning first reported a position in FLNA in Q3 2013 and held it in 18 quarters. The position peaked at $1.13M in Q3 2021. 137 funds tracked by Wall St. Rank hold FLNA as of Q4 2024.

  • Creative Planning reported no remaining Filana Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Creative Planning sold 6,831 Filana Therapeutics shares in Q4 2024, an estimated $201K.
  • Creative Planning first reported a position in Filana Therapeutics in Q3 2013 and held it in 18 quarters.
  • Creative Planning's Filana Therapeutics position peaked at $1.13M in Q3 2021.
  • 137 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2024.

Based on Creative Planning's 13F filing for Q4 2024, filed 14 Feb 2025.